Thalidomide in dermatology. New indications for an old drug
- 1 December 1997
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 36 (12) , 881-887
- https://doi.org/10.1046/j.1365-4362.1997.00298.x
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomideLife Sciences, 1995
- Prurigo nodularis and photosensitivity in AIDS: Treatment with thalidomideJournal of the American Academy of Dermatology, 1995
- Treatment of cutaneous and pulmonary sarcoidosis with thalidomideJournal of the American Academy of Dermatology, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide: Treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virusJournal of the American Academy of Dermatology, 1993
- Thalidomide in Human Immunodeficiency Virus (HIV) PatientsDrug Safety, 1992
- Pyoderma gangrenosum associated with Behçet's disease: Treatment with thalidomideJournal of the American Academy of Dermatology, 1990
- Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: Successful treatment with thalidomideJournal of the American Academy of Dermatology, 1990
- Significant response of oral aphthosis to thalidomide treatmentJournal of the American Academy of Dermatology, 1985